Novel emerging biomarkers to immunotherapy in kidney cancer

The treatment of metastatic renal cell carcinoma has significantly evolved in recent years, particularly with the advent of novel immune checkpoint inhibitors (ICI). Despite the striking benefits observed on a population level, outcomes vary and some patients do not respond to ICI-based regimens, ul...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Yasser Ged, Martin H. Voss
Formato: article
Lenguaje:EN
Publicado: SAGE Publishing 2021
Materias:
Acceso en línea:https://doaj.org/article/85f04da038e547b387181e4738d986d2
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares